Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Precipio Inc (PRPO) USD0.01

Sell:$2.20 Buy:$2.25 Change: $0.13 (5.51%)
NASDAQ:0.04%
Market closed |  Prices as at close on 14 November 2019 | Switch to live prices |
Sell:$2.20
Buy:$2.25
Change: $0.13 (5.51%)
Market closed |  Prices as at close on 14 November 2019 | Switch to live prices |
Sell:$2.20
Buy:$2.25
Change: $0.13 (5.51%)
Market closed |  Prices as at close on 14 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Precipio, Inc., formerly Transgenomic, Inc., is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted.

Contact details

Address:
12325 Emmet St
OMAHA
68164-4243
United States
Telephone:
+1 (203) 7877888
Website:
www.transgenomic.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PRPO
ISIN:
US74019L5030
Market cap:
$14.20 million
Shares in issue:
6.09 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Samuel Riccitelli
    Chairman of the Board
  • Ilan Danieli
    President, Chief Executive Officer, Director
  • Carl Iberger
    Chief Financial Officer
  • Douglas Sites
    Vice President - Sales
  • Ori Karev
    Chief Strategy Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.